FINANCIAL STATEMENT ANALYSIS

USED BY US DEPARTMEN OF EDUCATION, UNIVERSITIES, STUDENTS & ACCOUNTING PRO'S

VentureLine tracks and provides 5-year financial statement analysis on approximately 7,000+ publicly traded companies; the SEC-traceable data is updated weekly. For your convenience you can access that current company financial statement analysis information by clicking directly on the Company Name, visit their Website or enter the Company name or Ticker symbol, e.g. enter 'Microsoft' or 'MSFT' for Microsoft, in the Company Search window below.

FINANCIAL STATEMENT ANALYSIS UPDATED: JULY 24, 2022

Results 251 through 269 of 269

- SIC # 2830

Ticker Exchange Company Financial Reports SIC #
VCEL Nasdaq Vericel Corporation 2830
VERV Nasdaq Verve Therapeutics, Inc. 2830
VIGL Nasdaq Vigil Neuroscience, Inc. 2830
VIR Nasdaq Vir Biotechnology, Inc. 2830
VKTX Nasdaq Viking Therapeutics, Inc. 2830
VRNA Nasdaq Verona Pharma plc 2830
VSTM Nasdaq Verastem, Inc. 2830
VTVT Nasdaq vTv Therapeutics Inc. 2830
VTYX Nasdaq Ventyx Biosciences, Inc. 2830
WVE Nasdaq Wave Life Sciences Ltd. 2830
XAIR Nasdaq Beyond Air, Inc. 2830
XBIT Nasdaq XBiotech Inc. 2830
XCUR Nasdaq Exicure, Inc. 2830
XERS Nasdaq Xeris Biopharma Holdings, Inc. 2830
XOMA Nasdaq XOMA Royalty Corporation 2830
XTLB Nasdaq XTL Biopharmaceuticals Ltd. 2830
ZURA Nasdaq Zura Bio Limited 2830
ZVSA Nasdaq ZyVersa Therapeutics, Inc. 2830
ZYBT Nasdaq Zhengye Biotechnology Holding Limited 2830
Results 250 through 269 of 269